Research monograph · dual-peptide blend: bpc-157 (15-aa pentadecapeptide) + tb-500 (43-aa active fragment of thymosin beta-4)
Combined Tissue Repair Studies
This monograph collects what the published literature reports about BPC-157 / TB-500 — its mechanisms, the areas it is studied in, its molecular record and the sources behind them. The two appear together in repair research because their described routes differ: BPC-157 is associated with angiogenic and growth-factor signaling, while TB-500 acts on actin dynamics and cell migration. Studies of the individual components are far more numerous than studies of the pair.
For laboratory research use only — not for human or animal use
Mechanisms
Angiogenesis & Cytoprotection
The BPC-157 component contributes the vascular arm — raised VEGF expression and new vessel formation, restoring supply to the injured area.
Cell Migration & Actin Regulation
The TB-500 component sequesters G-actin and enables the cytoskeletal remodeling a cell needs in order to move toward the site.
Complementary Repair Cascade
The pairing is studied on the logic that one component restores supply while the other mobilises the cells that use it. Worth noting: the published research addresses each compound separately, not the combination.
Studied applications
Both constituents appear separately in tendon and ligament literature; the combination itself has not been studied at that level.
Chang et al. 2014
Closure rate is measured, with the two components contributing vascular supply and cell migration respectively.
Malinda et al. 2007
Vessel formation comes from the BPC-157 arm and underpins the rest — repair elsewhere depends on restored supply.
Sikiric et al. 2019
Cytokine and macrophage endpoints are attributed mainly to the TB-500 component in the published work.
Sikiric et al. 2011
What the published work measures
The endpoints reported across the literature for this compound. The figures belong to the individual papers, not to us.
Reference values
Scroll for full molecular data →
| Physical form | Lyophilized powder blend |
|---|---|
| Documented purity | Quantified by HPLC, reported per lot |
| Storage | -20°C for long-term stability |
| Solubility | Water-soluble |
| Available sizes | 20mg |
FAQ
A combination vial pairing BPC-157 with TB-500 at 20 mg total. The two appear together in repair research because their described routes differ: BPC-157 is associated with angiogenic and growth-factor signaling, while TB-500 acts on actin dynamics and cell migration. Studies of the individual components are far more numerous than studies of the pair.
Published research on BPC-157 / TB-500 concentrates on Tendon & Ligament, Wound Healing, Vascular Repair and Inflammation Control. Each of those areas is summarised further up this page with the citation it comes from, and the full reference list — 4 indexed publications — sits at the bottom. Study designs and concentrations vary considerably between publications, so the primary sources are worth reading directly.
The literature describes BPC-157 / TB-500 acting across Angiogenesis & Cytoprotection, Cell Migration & Actin Regulation and Complementary Repair Cascade, reported respectively as BPC-157, TB-500 and Synergy. Those pathways are drawn from preclinical models rather than clinical work, and they describe what has been observed rather than a settled mechanism — the individual pathway cards above cite what each one is based on.
Store the sealed vial at -20°C, protected from light and moisture, and let it reach room temperature before opening so condensation does not form on cold powder. BPC-157 / TB-500 is water-soluble; reconstitute by directing the diluent down the vial wall rather than onto the powder, then swirl to dissolve rather than shaking. Keep reconstituted solution refrigerated and avoid repeated freeze-thaw cycles — solutions are far less stable than lyophilized powder.
No. BPC-157 / TB-500 is supplied strictly for in-vitro laboratory research and development. It is not a drug, food, supplement or cosmetic, it has not been evaluated by the FDA, and it is not intended for human or animal consumption, ingestion, injection or any in-vivo use. Ordering confirms you are a qualified researcher or institution purchasing on that basis.
Cited sources
Independent published research indexed from PubMed — not Routine Peptides claims.
Before you order
Every production run is analyzed by an independent laboratory, and the certificate for your lot travels with the order — not a catalog-wide document, and not a summary written by us.
